EN
HI
Summary
As of 25 Aug, 2026, Gennex Laboratories stock price is ₹12.15. During the trading session, the stock has moved between an intraday low of ₹12.00 and an intraday high of ₹12.98. Over the last 52 weeks, Gennex Laboratories has traded between ₹7.05 and ₹17.25.
The stock has recorded a trading volume of 6,87,585 shares, with a market capitalization of ₹242947674. Its Average Traded Price (ATP) is ₹12.27, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 160 @ ₹12.15.
Gennex Laboratories has an upper circuit limit of ₹14.44 and a lower circuit limit of ₹9.64. The total value traded stands at ₹84.37 L, and the delivery percentage for the day is 85.72%.
The stock is currently traded with a market lot size of 1. Gennex Laboratories also offers a dividend yield of 0%.
Gennex Laboratories share price chart
Gennex Laboratories Share Key Metrics
Volume
6.88 L
Market Cap
295.18 CR
LTQ@LTP
160@12.15
ATP
12.27
Var Margin
50 %
Circuit Range
9.64-14.44
Delivery %
85.72 %
Value
84.37 L
ASM/GSM
No
Market Lot
1
Gennex Laboratories Fundamentals
P/E Ratio
15.08
P/B Ratio
1.29
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Gennex Laboratories Resistance and Support
Pivot 12.17
Resistance
First Resistance
12.67
Second Resistance
13.3
Third Resistance
13.8
Support
First Support
11.54
Second Support
11.04
Third Support
10.41
Gennex Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 12 | 12.15 | 1.00% | 12.98 | 12 |
| Mon Aug 24 2026 | 12.73 | 12.03 | -4.90% | 12.8 | 11.67 |
| Fri Aug 21 2026 | 11.77 | 12.65 | 8.21% | 12.89 | 11.31 |
Gennex Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-04-16 | Others |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-04 | A.G.M. |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Others |
| 2024-08-14 | Quarterly Results |
Gennex Laboratories News
Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026
Gennex Laboratories' board approved Q1 FY27 cons. financial results. Cons. revenue increased 16.57% YoY to ₹39.84 crores, while cons. net profit decreased 7.00% YoY to ₹4.67 crores. Standalone revenue grew 35.25% YoY to ₹34.68 crores.
Aug 14 2026 16:56:22
Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Gennex Laboratories will hold a board meeting on August 14, 2026, to consider and adopt the unaudited standalone and consolidated financial statements for Q1 FY27, along with the limited review report from auditors.
Jul 29 2026 14:36:27
Gennex Laboratories Management
| Name | Position |
|---|---|
| Dinesh Kumar Kejriwal | Company Secretary & Compliance Officer |
| Arihant Baid | Managing Director |
Gennex Laboratories FAQs
The Buying Price of Gennex Laboratories share is 12.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gennex Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gennex Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gennex Laboratories shares is 15.08. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gennex Laboratories shares is 1.29. Useful to assess the stock's value relative to its book value.
To assess Gennex Laboratories’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gennex Laboratories is 295.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gennex Laboratories share price is 17.25 & 7.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gennex Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
